Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review-Reference-Cited by-同舟云学术

Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review

Published:2014-01-20 Issue:1 Volume:9 Page:e84247
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Francis Jasmine H.,Abramson David H.,Gobin Y. Pierre,Marr Brian P.,Dunkel Ira J.,Riedel Elyn R.,Brodie Scott E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients;P Schaiquevich;Invest Ophthalmol Vis Sci,2012

2. Pharmacokinetic analysis of topotecan after superselective ophthalmic artery infusion and periocular administration in a porcine model;P Schaiquevich;Retina (Philadelphia, Pa),2012

3. Spontaneously Resolving Periocular Erythema and Ciliary Madarosis Following Intra-arterial Chemotherapy for Retinoblastoma;B Marr;Middle East Afr J Ophthalmol,2010

4. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma;SE Brodie;Doc Ophthalmol,2009

5. Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment;S Palioura;Pediatr Blood Cancer,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of intravitreal chemotherapy in the management of retinoblastoma: A systematic review of the literature;Critical Reviews in Oncology/Hematology;2024-08

2. Electroretinographic changes in the inner and outer retinal layers before and after intravenous chemotherapy for retinoblastoma;Indian Journal of Ophthalmology;2024-07-29

3. Therapy for Vitreous Seeding Caused by Retinoblastoma. A Review;Czech and Slovak Ophthalmology;2023-07-30

4. Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes;OncoTargets and Therapy;2022-12

5. Treatment-Refractory Nodular Scleritis;JAMA Ophthalmology;2022-11-01